Dr. Scadden discusses which blood cancer patients are eligible for stem cell transplantation, as well as the latest advances in the field.
Management of Gastrointestinal Toxicities From Ixazomib: Tips to Curb Nausea, Vomiting, Diarrhea, and Constipation
An oncology pharmacist discusses how to manage GI toxicities in multiple myeloma patients.
This review focuses on clinical developments and management of newly diagnosed glioblastoma, and includes a discussion about the incorporation of molecular features into the classification of this disease.
In this article, we review the new developments in neoadjuvant therapy for lung cancer.
A 39-year-old man is diagnosed with pure post-pubertal teratoma of the testis. What are the best steps of management?
Dr. Ku discusses considerations in the treatment of esophageal cancer, current treatments, and the emerging role of immunotherapy.
Integrating Novel Targets and Precision Medicine Into Prostate Cancer Care—Part 1: The Non-Androgen–Targetable Pathways in Castration-Resistant Prostate Cancer
Here, we review the current use and future direction of novel therapeutic targets in the treatment of castration-resistant prostate cancer.